Checkpoint Trends Limited Stock

Equities

RUBRAME6

INE396H01019

Delayed Bombay S.E. 00:45:00 2024-06-26 EDT 5-day change 1st Jan Change
9.1 INR -1.94% Intraday chart for Checkpoint Trends Limited -3.91% +96.12%

Financials

Sales 2022 20.12M 241K 329K Sales 2023 11.62M 139K 190K Capitalization 25.81M 309K 422K
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 0.78 x
Net cash position 2022 537K 6.42K 8.79K Net Debt 2023 939K 11.24K 15.38K EV / Sales 2023 2.3 x
P/E ratio 2022
-42.1 x
P/E ratio 2023
-32.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024 CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Checkpoint Trends Limited Announces Resignation of Komal Behl, Company Secretary CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Checkpoint Trends Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Checkpoint Trends Limited Announces Company Secretary Changes CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Rubra Medicaments Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Rubra Medicaments Gets Board Approval to Change Name MT
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
1 day-1.94%
1 week-3.91%
Current month+2.36%
1 month-7.43%
3 months-3.29%
6 months+108.24%
Current year+96.12%
More quotes
1 week
9.10
Extreme 9.1
9.47
1 month
7.25
Extreme 7.25
10.00
Current year
4.87
Extreme 4.87
12.39
1 year
3.76
Extreme 3.76
12.39
3 years
2.27
Extreme 2.27
12.39
5 years
1.18
Extreme 1.18
12.39
10 years
1.18
Extreme 1.18
12.39
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 16-06-13
Members of the board TitleAgeSince
Director of Finance/CFO - 16-06-13
Director/Board Member - 17-07-06
Director/Board Member - 19-06-10
More insiders
Date Price Change Volume
24-06-26 9.1 -1.94% 1 001
24-06-25 9.28 -1.90% 358
24-06-24 9.46 -0.11% 10
24-06-20 9.47 0.00% 5

Delayed Quote Bombay S.E., June 26, 2024 at 12:45 am

More quotes
  1. Stock Market
  2. Equities
  3. RUBRAME6 Stock